Pharma Bio-World - National, Feb. 2009

TROIKAA PHARMACEUTICALS TO RECEIVE DSIR AWARD FOR R&D EFFORTS

Troikaa Pharmaceuticals Ltd. Is to be conferred with the DSIR National Award for R&D efforts in the industry in 2008.  The company will receive the award for successfully developing, through its in-house R&D, the world's first painless Diclofenac Injection marketed as Dynapar AQ Injection.  The award will be conferred by the Ministry of Science & Technology, Government of India, in the 22nd National Conference on in-house R&D in the industry to be organised by the DSIR.  Mr. Ketan Patel, Managing Director, Troikaa Pharmaceuticals said, “Our focus has always been to address unmet medical needs through innovative drug delivery. We are glad to receive this award as it highlights our excellent track record of research work on new drug delivery systems & innovations.  “Diclofenac injections are routinely used for the management of acute pain and inflammation.  Dynapar AQ painless injections are the only diclofenac injections in the world that can be administered in the arm muscles.

The novel drug delivery composition and the process of its manufacturing have been patented in 28 countries.  In another 71 countries, the process of sealing the patents is in progress.  Troikaa Pharmaceuticals is a fast growing healthcare company based in Ahmedabad that commenced its commercial activities in the year 1984.  Dedicated to improving human life, the company develops, manufactures and markets superior products and services that improve the quality of life and satisfy customer needs.

Troikaa's state-of-the-art manufacturing facilities are certified by the World Health Organisation for following Good Manufacturing Practices and its Quality Management Systems are certified by KVQA for following ISO 9001:2000 standards for the manufacture and supply of drugs and pharmaceuticals.